• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Medipharm Labs Corp (OP:MEDIF)

    0.0620 -0.0015 (-2.36%)
    Streaming Delayed Price Updated: 11:44 AM EDT, May 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Medipharm Labs Corp

    < Previous 1 2 3 4 5 Next >
    News headline image
    MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs to Enter New Market with Costa Rica Supply Agreement
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Completes First Shipment to France
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    Apollo Capital Wins Proxy Contest at MediPharm Labs
    From Apollo Technology Capital Corporation
    Via GlobeNewswire
    News headline image
    Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
    Shareholders Urged to Vote for Proven Strategy and Team, Reject Dissident’s Inadequate Plan and Nominees 
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company
    From Apollo Technology Capital Corporation
    Via GlobeNewswire
    News headline image
    This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago ↗
    Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's the full recap. 
    Via Benzinga
    Topics Cannabis
    News headline image
    MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
    ISS concludes that Apollo “has not presented a compelling case for change” 
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
    From Apollo Technology Capital Corporation
    Via GlobeNewswire
    News headline image
    MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    Alleged Securities Fraud at MediPharm Labs Says Apollo Capital
    From Apollo Technology Capital Corporation
    Via GlobeNewswire
    News headline image
    MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
    From MediPharm Labs Corp.
    Via GlobeNewswire
    News headline image
    Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma
    From Apollo Technology Capital Corporation
    Via GlobeNewswire
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.